• LAST PRICE
    10.6001
  • TODAY'S CHANGE (%)
    Trending Up0.0301 (0.2848%)
  • Bid / Lots
    10.5400/ 10
  • Ask / Lots
    10.6400/ 4
  • Open / Previous Close
    10.6000 / 10.5700
  • Day Range
    Low 10.6000
    High 10.6200
  • 52 Week Range
    Low 10.0700
    High 11.1600
  • Volume
    7,200
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 10.57
TimeVolumeBLAC
12:17 ET77310.6
12:28 ET20010.6002
12:30 ET250010.6
12:32 ET140010.6
02:16 ET220010.6001
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBLAC
Bellevue Life Sciences Acquisition Corp
59.4M
171.4x
---
United StatesBNIX
Bannix Acquisition Corp
59.6M
-646.3x
---
United StatesEEA
The European Equity Fund Inc
59.7M
0.0x
---
United StatesHAIA
Healthcare AI Acquisition Corp
59.1M
14.7x
---
United StatesJVSAU
JVSPAC Acquisition Corp
58.6M
-1,347.4x
---
United StatesIGTA
Inception Growth Acquisition Ltd
60.5M
145.7x
---
As of 2024-02-24

Company Information

Bellevue Life Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The Company has not selected any business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company may pursue an acquisition opportunity in any business industry or sector. The Company intends to acquire and manage a business in the healthcare industry, more specifically in the biotechnology sector. The Company neither engaged in any operations nor generated any revenues.

Contact Information

Headquarters
10900 Ne 4Th Street, Suite 2300BELLEVUE, WA, United States 98004
Phone
425-635-7700
Fax
---

Executives

Independent Chairman of the Board
Steven Reed
Chief Executive Officer, Director
Kuk Hyoun Hwang
Chief Financial Officer
David Yoo
Director
Jun Chul Whang
Independent Director
In Chul Chung

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$59.4M
Revenue (TTM)
$0.00
Shares Outstanding
5.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.06
Book Value
$0.00
P/E Ratio
171.4x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.